We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$94.2M
Cap. Flow
+$29.6M
Cap. Flow %
2.64%
Top 10 Hldgs %
29.81%
Holding
2,679
New
140
Increased
832
Reduced
416
Closed
65

Sector Composition

Rank Sector Weight
1 Technology 5.59%
2 Healthcare 3.03%
3 Financials 2.86%
4 Industrials 2.37%
5 Consumer Discretionary 2.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTRX icon
2526
Quanterix
QTRX
$175M
$169 ﹤0.01%
13
TYRA icon
2527
Tyra Biosciences
TYRA
$1.91B
$165 ﹤0.01%
7
CUE icon
2528
Cue Biopharma
CUE
$113M
$163 ﹤0.01%
7
BBT
2529
Beacon Financial Corp
BBT
$2.69B
$162 ﹤0.01%
6
DFTX
2530
Definium Therapeutics
DFTX
$5.55B
$160 ﹤0.01%
28
INBX icon
2531
Inhibrx
INBX
$1.21B
$157 ﹤0.01%
10
ALTM
2532
DELISTED
Arcadium Lithium plc
ALTM
$157 ﹤0.01%
55
TELA icon
2533
TELA Bio
TELA
$33.1M
$152 ﹤0.01%
60
BPRN icon
2534
Princeton Bancorp
BPRN
$289M
$148 ﹤0.01%
4
IMXI icon
2535
International Money Express
IMXI
$369M
$148 ﹤0.01%
8
CLW icon
2536
Clearwater Paper
CLW
$359M
$143 ﹤0.01%
5
VEL icon
2537
Velocity Financial
VEL
$692M
$138 ﹤0.01%
7
LLAP
2538
DELISTED
Terran Orbital Corporation
LLAP
$136 ﹤0.01%
541
MTTR
2539
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$135 ﹤0.01%
30
FSBW icon
2540
FS Bancorp
FSBW
$314M
$134 ﹤0.01%
3
CRON
2541
Cronos Group
CRON
$1.06B
$132 ﹤0.01%
60
LYEL icon
2542
Lyell Immunopharma
LYEL
$315M
$132 ﹤0.01%
5
BOOM icon
2543
DMC Global
BOOM
$149M
$130 ﹤0.01%
10
-147
-94% -$1.86K
ASRT
2544
DELISTED
Assertio
ASRT
$124 ﹤0.01%
7
YOLO icon
2545
AdvisorShares Pure Cannabis ETF
YOLO
$30.2M
$124 ﹤0.01%
38
+1
+3% +$3
SGMO
2546
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$123 ﹤0.01%
142
XENE icon
2547
Xenon Pharmaceuticals
XENE
$6.02B
$119 ﹤0.01%
3
BDC icon
2548
Belden
BDC
$4.8B
$118 ﹤0.01%
1
CGEM icon
2549
Cullinan Oncology
CGEM
$999M
$118 ﹤0.01%
7
SBDS
2550
DELISTED
Solo Brands Inc
SBDS
$118 ﹤0.01%
2

Similar funds

Arax Advisory Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Arax Advisory Partners held 2,679 positions worth $1.12B, up 9.2% from $1.03B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Arax Advisory Partners's Q3 2024 filing shows 140 new, 832 increased, 416 reduced and 65 closed positions. Its largest new stake was iShares MSCI KLD 400 Social ETF: 739 shares worth $80.4K. The largest sale was First Trust US Equity Opportunities ETF, an estimated $8.47M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Financials.

  • Arax Advisory Partners's largest Q3 2024 buy was iShares MSCI KLD 400 Social ETF: 739 shares worth $80.4K.
  • Arax Advisory Partners added most to iShares Core US Aggregate Bond ETF in Q3 2024, an estimated $28.1M increase.
  • Arax Advisory Partners's biggest Q3 2024 reduction was First Trust US Equity Opportunities ETF, cutting an estimated $8.47M.
  • Arax Advisory Partners fully exited Vanguard Short-Term Inflation-Protected Securities Index Fund in Q3 2024, selling an estimated $259K.
  • Arax Advisory Partners's ten largest holdings make up 30% of its $1.12B portfolio in Q3 2024.
  • Arax Advisory Partners opened 140 new positions and closed 65 in Q3 2024.
  • Arax Advisory Partners's portfolio value rose 9.2% quarter-over-quarter to $1.12B.

Based on Arax Advisory Partners's 13F filing for Q3 2024, filed 6 Nov 2024.